Tenet Healthcare Corporation
$ 201.14
0.27%
29 Dec - close price
- Market Cap 17,770,920,000 USD
- Current Price $ 201.14
- High / Low $ 201.79 / 198.44
- Stock P/E 13.65
- Book Value 45.68
- EPS 14.74
- Next Earning Report 2026-02-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.27 %
- 52 Week High 222.81
- 52 Week Low 109.82
About
Tenet Healthcare Corporation (THC), based in Dallas, Texas, is a leading diversified healthcare services provider with a comprehensive network encompassing hospitals, outpatient centers, and ancillary care facilities. With a strong focus on delivering quality care and improving patient outcomes, Tenet integrates advanced technology and strategic partnerships to optimize operational efficiency. As the industry evolves, Tenet is strategically positioned for growth and is committed to enhancing its market presence, thereby reinforcing its leadership within the competitive healthcare landscape.
Analyst Target Price
$237.24
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-28 | 2025-07-22 | 2025-04-28 | 2025-02-06 | 2024-10-29 | 2024-07-24 | 2024-04-30 | 2024-02-08 | 2023-10-30 | 2023-07-31 | 2023-04-25 | 2023-02-09 |
| Reported EPS | 3.7 | 4.02 | 4.36 | 3.44 | 2.93 | 2.31 | 3.22 | 2.68 | 1.44 | 1.44 | 1.42 | 1.96 |
| Estimated EPS | 3.34 | 2.66 | 3.17 | 2.8324 | 2.37 | 1.9 | 1.43 | 1.6 | 1.2 | 1.25 | 1.16 | 1.23 |
| Surprise | 0.36 | 1.36 | 1.19 | 0.6076 | 0.56 | 0.41 | 1.79 | 1.08 | 0.24 | 0.19 | 0.26 | 0.73 |
| Surprise Percentage | 10.7784% | 51.1278% | 37.5394% | 21.4518% | 23.6287% | 21.5789% | 125.1748% | 67.5% | 20% | 15.2% | 22.4138% | 59.3496% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-11 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 4.05 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.01 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: THC
2025-12-26 15:08:43
This article from MSN (Microsoft Network) is about Tenet Healthcare Corporation (THC) and its earnings momentum. It highlights that ambulatory care is a key factor driving strong financial performance for the company. The specific details of the earnings and ambulatory care's contribution are expected to be elaborated within the full article.
2025-12-26 11:08:43
Swedbank AB significantly increased its stake in Tenet Healthcare Corporation (NYSE:THC) during the third quarter, boosting its holdings by 95.6% to 127,383 shares worth $25.86 million. This comes as Tenet Healthcare reported strong Q3 earnings, beating analyst estimates and issuing optimistic FY2025 guidance. The stock currently holds a "Moderate Buy" consensus rating from analysts, with insider selling also noted in recent transactions.
2025-12-25 14:05:00
Tenet Healthcare Corporation (THC) is experiencing strong earnings momentum, particularly driven by its ambulatory care segment. The company's Q3 2025 results showed a significant increase in adjusted EBITDA, and analysts have maintained positive ratings and price targets due to robust operational execution and growth in outpatient procedures. Tenet also raised its 2025 adjusted EBITDA guidance, reflecting continued profitability and effective cost management.
2025-12-22 13:09:22
Voya Investment Management LLC reduced its stake in Tenet Healthcare Corporation by 17.2% in Q3, now holding 106,266 shares valued at $21.58 million. Despite high institutional ownership (95.44%), insiders have been net sellers, offloading 45,500 shares worth $9.25 million. Tenet Healthcare reported strong Q3 earnings, beating expectations, and analysts maintain a "Moderate Buy" rating with an average target price of $231.81.
2025-12-21 12:09:23
Wedge Capital Management L L P NC reduced its stake in Tenet Healthcare Corporation (NYSE: THC) by 14.8% during the third quarter, selling 33,748 shares and owning 193,864 shares valued at $39.36 million. Tenet Healthcare recently beat Q3 earnings estimates, reporting $3.70 EPS against an estimated $3.33, and provided strong FY2025 guidance. The stock currently holds a "Moderate Buy" analyst rating with an average target price of $231.81.
2025-12-20 06:09:13
Tenet Healthcare (THC) is under investor scrutiny due to strong earnings and a potentially undervalued stock, despite policy debates regarding the Affordable Care Act and a Cigna contract dispute. While its current P/E ratio of 12.7x is significantly lower than industry averages, suggesting undervaluation, a discounted cash flow model indicates an even deeper value, with a fair value of around $370.12. However, these positive valuations are tempered by risks associated with potential changes to ACA subsidies and the outcome of the Cigna dispute.
